<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Mon, 07 Aug 2023 06:28:29 +0000</lastbuilddate>
<pubDate>Sat, 05 Aug 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37542484/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 27:S0735-1097(23)06030-8. doi: 10.1016/j.jacc.2023.06.014. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37542484/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37542484</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.014>10.1016/j.jacc.2023.06.014</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37542484</guid>
<pubDate>Sat, 05 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Martin S Maron</dc:creator>
<dc:creator>Matthew Mitten</dc:creator>
<dc:creator>James Borchers</dc:creator>
<dc:creator>Ethan J Rowin</dc:creator>
<dc:creator>Barry J Maron</dc:creator>
<dc:date>2023-08-05</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease</dc:title>
<dc:identifier>pmid:37542484</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.014</dc:identifier>
</item>
<item>
<title>The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37542118/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Millions of cardiomyocytes die immediately after myocardial infarction, regardless of whether the culprit coronary artery undergoes prompt revascularization. Residual ischaemia in the peri-infarct border zone causes further cardiomyocyte damage, resulting in a progressive decline in contractile function. To date, no treatment has succeeded in increasing the vascularization of the infarcted heart. In the past decade, new approaches that can target the heart's highly plastic perivascular niche...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Aug 4. doi: 10.1038/s41569-023-00913-y. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Millions of cardiomyocytes die immediately after myocardial infarction, regardless of whether the culprit coronary artery undergoes prompt revascularization. Residual ischaemia in the peri-infarct border zone causes further cardiomyocyte damage, resulting in a progressive decline in contractile function. To date, no treatment has succeeded in increasing the vascularization of the infarcted heart. In the past decade, new approaches that can target the heart's highly plastic perivascular niche have been proposed. The perivascular environment is populated by mesenchymal progenitor cells, fibroblasts, myofibroblasts and pericytes, which can together mount a healing response to the ischaemic damage. In the infarcted heart, pericytes have crucial roles in angiogenesis, scar formation and stabilization, and control of the inflammatory response. Persistent ischaemia and accrual of age-related risk factors can lead to pericyte depletion and dysfunction. In this Review, we describe the phenotypic changes that characterize the response of cardiac pericytes to ischaemia and the potential of pericyte-based therapy for restoring the perivascular niche after myocardial infarction. Pericyte-related therapies that can salvage the area at risk of an ischaemic injury include exogenously administered pericytes, pericyte-derived exosomes, pericyte-engineered biomaterials, and pharmacological approaches that can stimulate the differentiation of constitutively resident pericytes towards an arteriogenic phenotype. Promising preclinical results from in vitro and in vivo studies indicate that pericytes have crucial roles in the treatment of coronary artery disease and the prevention of post-ischaemic heart failure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37542118/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37542118</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00913-y>10.1038/s41569-023-00913-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37542118</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Elisa Avolio</dc:creator>
<dc:creator>Paola Campagnolo</dc:creator>
<dc:creator>Rajesh Katare</dc:creator>
<dc:creator>Paolo Madeddu</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction</dc:title>
<dc:identifier>pmid:37542118</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00913-y</dc:identifier>
</item>
<item>
<title>Snapshot: Choroid plexus brain barrier</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541203/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Located in each brain ventricle, choroid plexus (ChP) tissue forms a blood-CSF barrier and produces cerebrospinal fluid (CSF) and other supportive factors. Sheets of ChP epithelial cells enclose a vascularized stroma of mesenchymal, immune, and neuron/glia-like cells. Burgeoning ChP studies are revealing its complex set of functions across the lifespan. To view this SnapShot, open or download the PDF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3522-3522.e1. doi: 10.1016/j.cell.2023.07.015.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Located in each brain ventricle, choroid plexus (ChP) tissue forms a blood-CSF barrier and produces cerebrospinal fluid (CSF) and other supportive factors. Sheets of ChP epithelial cells enclose a vascularized stroma of mesenchymal, immune, and neuron/glia-like cells. Burgeoning ChP studies are revealing its complex set of functions across the lifespan. To view this SnapShot, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541203/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541203</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.015>10.1016/j.cell.2023.07.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541203</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Sivan Gelb</dc:creator>
<dc:creator>Maria K Lehtinen</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Snapshot: Choroid plexus brain barrier</dc:title>
<dc:identifier>pmid:37541203</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.015</dc:identifier>
</item>
<item>
<title>Sparse and stereotyped encoding implicates a core glomerulus for ant alarm behavior</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541202/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3521. doi: 10.1016/j.cell.2023.07.022.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541202/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541202</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.022>10.1016/j.cell.2023.07.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541202</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Taylor Hart</dc:creator>
<dc:creator>Dominic D Frank</dc:creator>
<dc:creator>Lindsey E Lopes</dc:creator>
<dc:creator>Leonora Olivos-Cisneros</dc:creator>
<dc:creator>Kip D Lacy</dc:creator>
<dc:creator>Waring Trible</dc:creator>
<dc:creator>Amelia Ritger</dc:creator>
<dc:creator>Stephany Valdés-Rodríguez</dc:creator>
<dc:creator>Daniel J C Kronauer</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Sparse and stereotyped encoding implicates a core glomerulus for ant alarm behavior</dc:title>
<dc:identifier>pmid:37541202</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.022</dc:identifier>
</item>
<item>
<title>Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541201/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3520. doi: 10.1016/j.cell.2023.06.025.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541201/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541201</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.025>10.1016/j.cell.2023.06.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541201</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Sajedah M Hindi</dc:creator>
<dc:creator>Michael J Petrany</dc:creator>
<dc:creator>Elena Greenfeld</dc:creator>
<dc:creator>Leah C Focke</dc:creator>
<dc:creator>Alyssa A W Cramer</dc:creator>
<dc:creator>Michael A Whitt</dc:creator>
<dc:creator>Ramzi J Khairallah</dc:creator>
<dc:creator>Christopher W Ward</dc:creator>
<dc:creator>Jeffrey S Chamberlain</dc:creator>
<dc:creator>Vikram Prasad</dc:creator>
<dc:creator>Benjamin Podbilewicz</dc:creator>
<dc:creator>Douglas P Millay</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery</dc:title>
<dc:identifier>pmid:37541201</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.025</dc:identifier>
</item>
<item>
<title>Large-scale snake genome analyses provide insights into vertebrate development</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541200/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3519. doi: 10.1016/j.cell.2023.06.021.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541200/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541200</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.021>10.1016/j.cell.2023.06.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541200</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Changjun Peng</dc:creator>
<dc:creator>Dong-Dong Wu</dc:creator>
<dc:creator>Jin-Long Ren</dc:creator>
<dc:creator>Zhong-Liang Peng</dc:creator>
<dc:creator>Zhifei Ma</dc:creator>
<dc:creator>Wei Wu</dc:creator>
<dc:creator>Yunyun Lv</dc:creator>
<dc:creator>Zeng Wang</dc:creator>
<dc:creator>Cao Deng</dc:creator>
<dc:creator>Ke Jiang</dc:creator>
<dc:creator>Christopher L Parkinson</dc:creator>
<dc:creator>Yin Qi</dc:creator>
<dc:creator>Zhi-Yi Zhang</dc:creator>
<dc:creator>Jia-Tang Li</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Large-scale snake genome analyses provide insights into vertebrate development</dc:title>
<dc:identifier>pmid:37541200</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.021</dc:identifier>
</item>
<item>
<title>Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541199/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>To improve the understanding of chemo-refractory high-grade serous ovarian cancers (HGSOCs), we characterized the proteogenomic landscape of 242 (refractory and sensitive) HGSOCs, representing one discovery and two validation cohorts across two biospecimen types (formalin-fixed paraffin-embedded and frozen). We identified a 64-protein signature that predicts with high specificity a subset of HGSOCs refractory to initial platinum-based therapy and is validated in two independent patient cohorts....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3476-3498.e35. doi: 10.1016/j.cell.2023.07.004.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">To improve the understanding of chemo-refractory high-grade serous ovarian cancers (HGSOCs), we characterized the proteogenomic landscape of 242 (refractory and sensitive) HGSOCs, representing one discovery and two validation cohorts across two biospecimen types (formalin-fixed paraffin-embedded and frozen). We identified a 64-protein signature that predicts with high specificity a subset of HGSOCs refractory to initial platinum-based therapy and is validated in two independent patient cohorts. We detected significant association between lack of Ch17 loss of heterozygosity (LOH) and chemo-refractoriness. Based on pathway protein expression, we identified 5 clusters of HGSOC, which validated across two independent patient cohorts and patient-derived xenograft (PDX) models. These clusters may represent different mechanisms of refractoriness and implicate putative therapeutic vulnerabilities.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541199/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541199</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.004>10.1016/j.cell.2023.07.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541199</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Shrabanti Chowdhury</dc:creator>
<dc:creator>Jacob J Kennedy</dc:creator>
<dc:creator>Richard G Ivey</dc:creator>
<dc:creator>Oscar D Murillo</dc:creator>
<dc:creator>Noshad Hosseini</dc:creator>
<dc:creator>Xiaoyu Song</dc:creator>
<dc:creator>Francesca Petralia</dc:creator>
<dc:creator>Anna Calinawan</dc:creator>
<dc:creator>Sara R Savage</dc:creator>
<dc:creator>Anna B Berry</dc:creator>
<dc:creator>Boris Reva</dc:creator>
<dc:creator>Umut Ozbek</dc:creator>
<dc:creator>Azra Krek</dc:creator>
<dc:creator>Weiping Ma</dc:creator>
<dc:creator>Felipe da Veiga Leprevost</dc:creator>
<dc:creator>Jiayi Ji</dc:creator>
<dc:creator>Seungyeul Yoo</dc:creator>
<dc:creator>Chenwei Lin</dc:creator>
<dc:creator>Uliana J Voytovich</dc:creator>
<dc:creator>Yajue Huang</dc:creator>
<dc:creator>Sun-Hee Lee</dc:creator>
<dc:creator>Lindsay Bergan</dc:creator>
<dc:creator>Travis D Lorentzen</dc:creator>
<dc:creator>Mehdi Mesri</dc:creator>
<dc:creator>Henry Rodriguez</dc:creator>
<dc:creator>Andrew N Hoofnagle</dc:creator>
<dc:creator>Zachary T Herbert</dc:creator>
<dc:creator>Alexey I Nesvizhskii</dc:creator>
<dc:creator>Bing Zhang</dc:creator>
<dc:creator>Jeffrey R Whiteaker</dc:creator>
<dc:creator>David Fenyo</dc:creator>
<dc:creator>Wilson McKerrow</dc:creator>
<dc:creator>Joshua Wang</dc:creator>
<dc:creator>Stephan C Schürer</dc:creator>
<dc:creator>Vasileios Stathias</dc:creator>
<dc:creator>X Steven Chen</dc:creator>
<dc:creator>Mary Helen Barcellos-Hoff</dc:creator>
<dc:creator>Timothy K Starr</dc:creator>
<dc:creator>Boris J Winterhoff</dc:creator>
<dc:creator>Andrew C Nelson</dc:creator>
<dc:creator>Samuel C Mok</dc:creator>
<dc:creator>Scott H Kaufmann</dc:creator>
<dc:creator>Charles Drescher</dc:creator>
<dc:creator>Marcin Cieslik</dc:creator>
<dc:creator>Pei Wang</dc:creator>
<dc:creator>Michael J Birrer</dc:creator>
<dc:creator>Amanda G Paulovich</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer</dc:title>
<dc:identifier>pmid:37541199</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.004</dc:identifier>
</item>
<item>
<title>Dual pathogenicity island transfer by piggybacking lateral transduction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541198/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Lateral transduction (LT) is the process by which temperate phages mobilize large sections of bacterial genomes. Despite its importance, LT has only been observed during prophage induction. Here, we report that superantigen-carrying staphylococcal pathogenicity islands (SaPIs) employ a related but more versatile and complex mechanism of gene transfer to drive chromosomal hypermobility while self-transferring with additional virulence genes from the host. We found that after phage infection or...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3414-3426.e16. doi: 10.1016/j.cell.2023.07.001.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Lateral transduction (LT) is the process by which temperate phages mobilize large sections of bacterial genomes. Despite its importance, LT has only been observed during prophage induction. Here, we report that superantigen-carrying staphylococcal pathogenicity islands (SaPIs) employ a related but more versatile and complex mechanism of gene transfer to drive chromosomal hypermobility while self-transferring with additional virulence genes from the host. We found that after phage infection or prophage induction, activated SaPIs form concatamers in the bacterial chromosome by switching between parallel genomic tracks in replication bubbles. This dynamic life cycle enables SaPIbov1 to piggyback its LT of staphylococcal pathogenicity island vSaα, which encodes an array of genes involved in host-pathogen interactions, allowing both islands to be mobilized intact and transferred in a single infective particle. Our findings highlight previously unknown roles of pathogenicity islands in bacterial virulence and show that their evolutionary impact extends beyond the genes they carry.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541198/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541198</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.001>10.1016/j.cell.2023.07.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541198</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Melissa Su Juan Chee</dc:creator>
<dc:creator>Ester Serrano</dc:creator>
<dc:creator>Yin Ning Chiang</dc:creator>
<dc:creator>Joshua Harling-Lee</dc:creator>
<dc:creator>Rebecca Man</dc:creator>
<dc:creator>Rodrigo Bacigalupe</dc:creator>
<dc:creator>J Ross Fitzgerald</dc:creator>
<dc:creator>José R Penadés</dc:creator>
<dc:creator>John Chen</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Dual pathogenicity island transfer by piggybacking lateral transduction</dc:title>
<dc:identifier>pmid:37541198</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.001</dc:identifier>
</item>
<item>
<title>A widely distributed gene cluster compensates for uricase loss in hominids</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541197/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Approximately 15% of US adults have circulating levels of uric acid above its solubility limit, which is causally linked to the disease gout. In most mammals, uric acid elimination is facilitated by the enzyme uricase. However, human uricase is a pseudogene, having been inactivated early in hominid evolution. Though it has long been known that uric acid is eliminated in the gut, the role of the gut microbiota in hyperuricemia has not been studied. Here, we identify a widely distributed bacterial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3400-3413.e20. doi: 10.1016/j.cell.2023.06.010.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Approximately 15% of US adults have circulating levels of uric acid above its solubility limit, which is causally linked to the disease gout. In most mammals, uric acid elimination is facilitated by the enzyme uricase. However, human uricase is a pseudogene, having been inactivated early in hominid evolution. Though it has long been known that uric acid is eliminated in the gut, the role of the gut microbiota in hyperuricemia has not been studied. Here, we identify a widely distributed bacterial gene cluster that encodes a pathway for uric acid degradation. Stable isotope tracing demonstrates that gut bacteria metabolize uric acid to xanthine or short chain fatty acids. Ablation of the microbiota in uricase-deficient mice causes severe hyperuricemia, and anaerobe-targeted antibiotics increase the risk of gout in humans. These data reveal a role for the gut microbiota in uric acid excretion and highlight the potential for microbiome-targeted therapeutics in hyperuricemia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541197/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541197</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.010>10.1016/j.cell.2023.06.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541197</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Yuanyuan Liu</dc:creator>
<dc:creator>J Bryce Jarman</dc:creator>
<dc:creator>Yen S Low</dc:creator>
<dc:creator>Hannah E Augustijn</dc:creator>
<dc:creator>Steven Huang</dc:creator>
<dc:creator>Haoqing Chen</dc:creator>
<dc:creator>Mary E DeFeo</dc:creator>
<dc:creator>Kazuma Sekiba</dc:creator>
<dc:creator>Bi-Huei Hou</dc:creator>
<dc:creator>Xiandong Meng</dc:creator>
<dc:creator>Allison M Weakley</dc:creator>
<dc:creator>Ashley V Cabrera</dc:creator>
<dc:creator>Zhiwei Zhou</dc:creator>
<dc:creator>Gilles van Wezel</dc:creator>
<dc:creator>Marnix H Medema</dc:creator>
<dc:creator>Calyani Ganesan</dc:creator>
<dc:creator>Alan C Pao</dc:creator>
<dc:creator>Saurabh Gombar</dc:creator>
<dc:creator>Dylan Dodd</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A widely distributed gene cluster compensates for uricase loss in hominids</dc:title>
<dc:identifier>pmid:37541197</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.010</dc:identifier>
</item>
<item>
<title>PIEZO2 in somatosensory neurons controls gastrointestinal transit</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541196/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>The gastrointestinal tract is in a state of constant motion. These movements are tightly regulated by the presence of food and help digestion by mechanically breaking down and propelling gut content. Mechanical sensing in the gut is thought to be essential for regulating motility; however, the identity of the neuronal populations, the molecules involved, and the functional consequences of this sensation are unknown. Here, we show that humans lacking PIEZO2 exhibit impaired bowel sensation and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3386-3399.e15. doi: 10.1016/j.cell.2023.07.006.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The gastrointestinal tract is in a state of constant motion. These movements are tightly regulated by the presence of food and help digestion by mechanically breaking down and propelling gut content. Mechanical sensing in the gut is thought to be essential for regulating motility; however, the identity of the neuronal populations, the molecules involved, and the functional consequences of this sensation are unknown. Here, we show that humans lacking PIEZO2 exhibit impaired bowel sensation and motility. Piezo2 in mouse dorsal root, but not nodose ganglia is required to sense gut content, and this activity slows down food transit rates in the stomach, small intestine, and colon. Indeed, Piezo2 is directly required to detect colon distension in vivo. Our study unveils the mechanosensory mechanisms that regulate the transit of luminal contents throughout the gut, which is a critical process to ensure proper digestion, nutrient absorption, and waste removal.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541196/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541196</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.006>10.1016/j.cell.2023.07.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541196</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>M Rocio Servin-Vences</dc:creator>
<dc:creator>Ruby M Lam</dc:creator>
<dc:creator>Alize Koolen</dc:creator>
<dc:creator>Yu Wang</dc:creator>
<dc:creator>Dimah N Saade</dc:creator>
<dc:creator>Meaghan Loud</dc:creator>
<dc:creator>Halil Kacmaz</dc:creator>
<dc:creator>Suzanne Frausto</dc:creator>
<dc:creator>Yunxiao Zhang</dc:creator>
<dc:creator>Arthur Beyder</dc:creator>
<dc:creator>Kara L Marshall</dc:creator>
<dc:creator>Carsten G Bönnemann</dc:creator>
<dc:creator>Alexander T Chesler</dc:creator>
<dc:creator>Ardem Patapoutian</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>PIEZO2 in somatosensory neurons controls gastrointestinal transit</dc:title>
<dc:identifier>pmid:37541196</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.006</dc:identifier>
</item>
<item>
<title>DRG afferents that mediate physiologic and pathologic mechanosensation from the distal colon</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541195/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>The properties of dorsal root ganglia (DRG) neurons that innervate the distal colon are poorly defined, hindering our understanding of their roles in normal physiology and gastrointestinal (GI) disease. Here, we report genetically defined subsets of colon-innervating DRG neurons with diverse morphologic and physiologic properties. Four colon-innervating DRG neuron populations are mechanosensitive and exhibit distinct force thresholds to colon distension. The highest threshold population,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3368-3385.e18. doi: 10.1016/j.cell.2023.07.007.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The properties of dorsal root ganglia (DRG) neurons that innervate the distal colon are poorly defined, hindering our understanding of their roles in normal physiology and gastrointestinal (GI) disease. Here, we report genetically defined subsets of colon-innervating DRG neurons with diverse morphologic and physiologic properties. Four colon-innervating DRG neuron populations are mechanosensitive and exhibit distinct force thresholds to colon distension. The highest threshold population, selectively labeled using Bmpr1b genetic tools, is necessary and sufficient for behavioral responses to high colon distension, which is partly mediated by the mechanosensory ion channel Piezo2. This Aδ-HTMR population mediates behavioral over-reactivity to colon distension caused by inflammation in a model of inflammatory bowel disease. Thus, like cutaneous DRG mechanoreceptor populations, colon-innervating mechanoreceptors exhibit distinct anatomical and physiological properties and tile force threshold space, and genetically defined colon-innervating HTMRs mediate pathophysiological responses to colon distension, revealing a target population for therapeutic intervention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541195/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541195</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.007>10.1016/j.cell.2023.07.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541195</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Rachel L Wolfson</dc:creator>
<dc:creator>Amira Abdelaziz</dc:creator>
<dc:creator>Genelle Rankin</dc:creator>
<dc:creator>Sarah Kushner</dc:creator>
<dc:creator>Lijun Qi</dc:creator>
<dc:creator>Ofer Mazor</dc:creator>
<dc:creator>Seungwon Choi</dc:creator>
<dc:creator>Nikhil Sharma</dc:creator>
<dc:creator>David D Ginty</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>DRG afferents that mediate physiologic and pathologic mechanosensation from the distal colon</dc:title>
<dc:identifier>pmid:37541195</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.007</dc:identifier>
</item>
<item>
<title>Neurokinin 3 receptor antagonism for menopausal hot flashes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541194/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Menopausal hot flashes are common and debilitating. Menopausal Hormone Therapy (MHT) is effective for hot flashes but has risks and side effects that limit its use. NK3 receptor antagonism has emerged as a novel therapeutic strategy, leading to the recent FDA approval of fezolinetant, a first-in-class nonhormonal treatment for menopausal hot flashes. To view this Bench to Bedside, open or download the PDF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3332-3332.e1. doi: 10.1016/j.cell.2023.07.011.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Menopausal hot flashes are common and debilitating. Menopausal Hormone Therapy (MHT) is effective for hot flashes but has risks and side effects that limit its use. NK3 receptor antagonism has emerged as a novel therapeutic strategy, leading to the recent FDA approval of fezolinetant, a first-in-class nonhormonal treatment for menopausal hot flashes. To view this Bench to Bedside, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541194/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541194</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.011>10.1016/j.cell.2023.07.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541194</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alexander N Comninos</dc:creator>
<dc:creator>Waljit S Dhillo</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Neurokinin 3 receptor antagonism for menopausal hot flashes</dc:title>
<dc:identifier>pmid:37541194</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.011</dc:identifier>
</item>
<item>
<title>Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541193/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>The lysosomal membrane protein TMEM106B functions as a proviral factor in SARS-CoV-2 infection, though it was not known how. In this issue of Cell, Baggen et al. demonstrate that TMEM106B serves as an ACE2-independent receptor for SARS-CoV-2 entry by promoting the fusion of the viral membrane with the lysosomal membrane.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3329-3331. doi: 10.1016/j.cell.2023.07.005.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The lysosomal membrane protein TMEM106B functions as a proviral factor in SARS-CoV-2 infection, though it was not known how. In this issue of Cell, Baggen et al. demonstrate that TMEM106B serves as an ACE2-independent receptor for SARS-CoV-2 entry by promoting the fusion of the viral membrane with the lysosomal membrane.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541193/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541193</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.005>10.1016/j.cell.2023.07.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541193</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alexander Lacrampe</dc:creator>
<dc:creator>Fenghua Hu</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Unveiling TMEM106B: SARS-CoV-2's secret entrance to the cell</dc:title>
<dc:identifier>pmid:37541193</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.005</dc:identifier>
</item>
<item>
<title>Toward imaging of alpha-synuclein with PET</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37541192/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 3;186(16):3327-3329. doi: 10.1016/j.cell.2023.06.018.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Development of radiopharmaceuticals for in vivo positron emission tomography imaging of alpha-synuclein aggregates has the potential to revolutionize Lewy body disease diagnosis and treatment. Reporting in this issue of Cell, Xiang et al. developed a high-affinity positron emission tomography tracer for alpha-synuclein.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37541192/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37541192</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.018>10.1016/j.cell.2023.06.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37541192</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Kejal Kantarci</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Toward imaging of alpha-synuclein with PET</dc:title>
<dc:identifier>pmid:37541192</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.018</dc:identifier>
</item>
<item>
<title>Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37539553/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 4. doi: 10.1161/CIRCRESAHA.123.323022. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37539553/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37539553</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323022>10.1161/CIRCRESAHA.123.323022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37539553</guid>
<pubDate>Fri, 04 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Michael E Widlansky</dc:creator>
<dc:creator>Yong Liu</dc:creator>
<dc:creator>Shakirah Tumusiime</dc:creator>
<dc:creator>Benjamin Hofeld</dc:creator>
<dc:creator>Nabeel Khan</dc:creator>
<dc:creator>Michael Aljadah</dc:creator>
<dc:creator>Jingli Wang</dc:creator>
<dc:creator>Amberly Anger</dc:creator>
<dc:creator>Qiongzi Qiu</dc:creator>
<dc:creator>Bhavika Therani</dc:creator>
<dc:creator>Pengyuan Liu</dc:creator>
<dc:creator>Mingyu Liang</dc:creator>
<dc:date>2023-08-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Coronary Plaque Sampling Reveals Molecular Insights Into Coronary Artery Disease</dc:title>
<dc:identifier>pmid:37539553</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323022</dc:identifier>
</item>
<item>
<title>Chromosome-level organization of the regulatory genome in the Drosophila nervous system</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37536338/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>Previous studies have identified topologically associating domains (TADs) as basic units of genome organization. We present evidence of a previously unreported level of genome folding, where distant TAD pairs, megabases apart, interact to form meta-domains. Within meta-domains, gene promoters and structural intergenic elements present in distant TADs are specifically paired. The associated genes encode neuronal determinants, including those engaged in axonal guidance and adhesion. These...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 25:S0092-8674(23)00741-9. doi: 10.1016/j.cell.2023.07.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Previous studies have identified topologically associating domains (TADs) as basic units of genome organization. We present evidence of a previously unreported level of genome folding, where distant TAD pairs, megabases apart, interact to form meta-domains. Within meta-domains, gene promoters and structural intergenic elements present in distant TADs are specifically paired. The associated genes encode neuronal determinants, including those engaged in axonal guidance and adhesion. These long-range associations occur in a large fraction of neurons but support transcription in only a subset of neurons. Meta-domains are formed by diverse transcription factors that are able to pair over long and flexible distances. We present evidence that two such factors, GAF and CTCF, play direct roles in this process. The relative simplicity of higher-order meta-domain interactions in Drosophila, compared with those previously described in mammals, allowed the demonstration that genomes can fold into highly specialized cell-type-specific scaffolds that enable megabase-scale regulatory associations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37536338/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37536338</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.008>10.1016/j.cell.2023.07.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37536338</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Giriram Mohana</dc:creator>
<dc:creator>Julien Dorier</dc:creator>
<dc:creator>Xiao Li</dc:creator>
<dc:creator>Marion Mouginot</dc:creator>
<dc:creator>Rebecca C Smith</dc:creator>
<dc:creator>Héléna Malek</dc:creator>
<dc:creator>Marion Leleu</dc:creator>
<dc:creator>Daniel Rodriguez</dc:creator>
<dc:creator>Jenisha Khadka</dc:creator>
<dc:creator>Patrycja Rosa</dc:creator>
<dc:creator>Pascal Cousin</dc:creator>
<dc:creator>Christian Iseli</dc:creator>
<dc:creator>Simon Restrepo</dc:creator>
<dc:creator>Nicolas Guex</dc:creator>
<dc:creator>Brian D McCabe</dc:creator>
<dc:creator>Aleksander Jankowski</dc:creator>
<dc:creator>Michael S Levine</dc:creator>
<dc:creator>Maria Cristina Gambetta</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Chromosome-level organization of the regulatory genome in the Drosophila nervous system</dc:title>
<dc:identifier>pmid:37536338</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.008</dc:identifier>
</item>
<item>
<title>Connecting the Dots From GWAS to Function in Atrial Fibrillation for &lt;em>;ZFHX3&lt;/em>;</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37535755/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 4;133(4):330-332. doi: 10.1161/CIRCRESAHA.123.323281. Epub 2023 Aug 3.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37535755/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37535755</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10403289/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">PMC10403289</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323281>10.1161/CIRCRESAHA.123.323281</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37535755</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Sojin Y Wass</dc:creator>
<dc:creator>Jonathan D Smith</dc:creator>
<dc:creator>Mina K Chung</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Connecting the Dots From GWAS to Function in Atrial Fibrillation for &lt;em>;ZFHX3&lt;/em>;</dc:title>
<dc:identifier>pmid:37535755</dc:identifier>
<dc:identifier>pmc:PMC10403289</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323281</dc:identifier>
</item>
<item>
<title>Mechanisms of Lymphatic Endothelial Cell Junction Transformations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37535754/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 4;133(4):350-352. doi: 10.1161/CIRCRESAHA.123.323210. Epub 2023 Aug 3.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37535754/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37535754</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323210>10.1161/CIRCRESAHA.123.323210</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37535754</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jianyong Zhong</dc:creator>
<dc:creator>Elaine L Shelton</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:creator>Valentina Kon</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Mechanisms of Lymphatic Endothelial Cell Junction Transformations</dc:title>
<dc:identifier>pmid:37535754</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323210</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37535753/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 4;133(4):296-297. doi: 10.1161/RES.0000000000000627. Epub 2023 Aug 3.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37535753/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37535753</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000627>10.1161/RES.0000000000000627</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37535753</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-03</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37535753</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000627</dc:identifier>
</item>
<item>
<title>Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37534453/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In patients with HFpEF, treatment with dapagliflozin reduces resting and exercise PCWP, along with the favorable effects on plasma volume and body weight. These findings provide new insight into the hemodynamic mechanisms of benefit with sodium-glucose cotransporter-2 inhibitors in HFpEF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Aug 3. doi: 10.1161/CIRCULATIONAHA.123.065134. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Sodium-glucose cotransporter-2 inhibitors reduce risk of hospitalization for heart failure in patients who have heart failure with preserved ejection fraction (HFpEF), but the hemodynamic mechanisms underlying these benefits remain unclear. This study sought to determine whether treatment with dapagliflozin affects pulmonary capillary wedge pressure (PCWP) at rest and during exercise in patients with HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a single-center, double-blinded, randomized, placebo-controlled trial testing the effects of 10 mg of dapagliflozin once daily in patients with HFpEF. Patients with New York Heart Association class II or III heart failure, ejection fraction ≥50%, and elevated PCWP during exercise were recruited. Cardiac hemodynamics were measured at rest and during exercise using high-fidelity micromanometers at baseline and after 24 weeks of treatment. The primary end point was a change from baseline in rest and peak exercise PCWPs that incorporated both measurements, and was compared using a mixed-model likelihood ratio test. Key secondary end points included body weight and directly measured blood and plasma volumes. Expired gas analysis was performed evaluate oxygen transport in tandem with arterial lactate sampling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 38 patients completing baseline assessments (median age 68 years; 66% women; 71% obese), 37 completed the trial. Treatment with dapagliflozin resulted in reduction in the primary end point of change in PCWP at rest and during exercise at 24 weeks relative to treatment with placebo (likelihood ratio test for overall changes in PCWP; <i>P</i>&lt;0.001), with lower PCWP at rest (estimated treatment difference [ETD], -3.5 mm Hg [95% CI, -6.6 to -0.4]; <i>P</i>=0.029) and maximal exercise (ETD, -5.7 mm Hg [95% CI, -10.8 to -0.7]; <i>P</i>=0.027). Body weight was reduced with dapagliflozin (ETD, -3.5 kg [95% CI, -5.9 to -1.1]; <i>P</i>=0.006), as was plasma volume (ETD, -285 mL [95% CI, -510 to -60]; <i>P</i>=0.014), but there was no significant effect on red blood cell volume. There were no differences in oxygen consumption at 20-W or peak exercise, but dapagliflozin decreased arterial lactate at 20 W (-0.70 ± 0.77 versus 0.37 ± 1.29 mM; <i>P</i>=0.006).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In patients with HFpEF, treatment with dapagliflozin reduces resting and exercise PCWP, along with the favorable effects on plasma volume and body weight. These findings provide new insight into the hemodynamic mechanisms of benefit with sodium-glucose cotransporter-2 inhibitors in HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICALTRIALS: gov; Unique identifier: NCT04730947.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37534453/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37534453</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065134>10.1161/CIRCULATIONAHA.123.065134</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37534453</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Barry A Borlaug</dc:creator>
<dc:creator>Yogesh N V Reddy</dc:creator>
<dc:creator>Amanda Braun</dc:creator>
<dc:creator>Hidemi Sorimachi</dc:creator>
<dc:creator>Massar Omar</dc:creator>
<dc:creator>Dejana Popovic</dc:creator>
<dc:creator>Alessio Alogna</dc:creator>
<dc:creator>Michael D Jensen</dc:creator>
<dc:creator>Rickey Carter</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial</dc:title>
<dc:identifier>pmid:37534453</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065134</dc:identifier>
</item>
<item>
<title>Using routinely collected health record data for the earlier detection of heart failure with preserved ejection fraction: FIND-HFpEF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37534410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230807022824&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 3:ehad440. doi: 10.1093/eurheartj/ehad440. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37534410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230807022824&v=2.17.9.post6+86293ac">37534410</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad440>10.1093/eurheartj/ehad440</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37534410</guid>
<pubDate>Thu, 03 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Ramesh Nadarajah</dc:creator>
<dc:creator>Yoko M Nakao</dc:creator>
<dc:creator>Jianhua Wu</dc:creator>
<dc:creator>Chris P Gale</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Using routinely collected health record data for the earlier detection of heart failure with preserved ejection fraction: FIND-HFpEF</dc:title>
<dc:identifier>pmid:37534410</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad440</dc:identifier>
</item>





























</channel>
</rss>